Advertisement

Advertisement

MAIA Stock Latest News

MAIA Biotechnology Shareholders Back Board and Auditor Appointments

Company AnnouncementsMAIA Biotechnology Shareholders Back Board and Auditor Appointments

MAIA Biotechnology Ends ATM Stock Offering Agreement

PremiumCompany Announcements

MAIA Biotechnology Ends ATM Stock Offering Agreement

9d ago

MAIA Expands THIO-101 Lung Cancer Trial in U.S.

PremiumCompany Announcements

MAIA Expands THIO-101 Lung Cancer Trial in U.S.

1M ago

MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial

PremiumCompany Announcements

MAIA Fully Funds Pivotal Phase 3 THIO-104 NSCLC Trial

2M ago

MAIA Biotechnology secures funding for clinical trial of ateganosine

PremiumThe Fly

MAIA Biotechnology secures funding for clinical trial of ateganosine

2M ago

MAIA Biotechnology Awards Executive Bonuses After Successful Financing

PremiumCompany AnnouncementsMAIA Biotechnology Awards Executive Bonuses After Successful Financing

2M ago

MAIA Highlights Promising Phase 2 NSCLC Survival Outcomes

Company Announcements

MAIA Highlights Promising Phase 2 NSCLC Survival Outcomes

2M ago

MAIA Showcases THIO-101 NSCLC Data at ELCC 2026

Company Announcements

MAIA Showcases THIO-101 NSCLC Data at ELCC 2026

2M ago

MAIA Biotechnology Completes $30 Million Public Stock Offering

PremiumCompany Announcements

MAIA Biotechnology Completes $30 Million Public Stock Offering

3M ago

MAIA Biotechnology 20M share Spot Secondary priced at $1.50

PremiumThe Fly

MAIA Biotechnology 20M share Spot Secondary priced at $1.50

3M ago

MAIA Biotechnology announces common stock offering, no amount given

PremiumThe Fly

MAIA Biotechnology announces common stock offering, no amount given

3M ago

MAIA Biotechnology Highlights Progress in Phase 3 Oncology Program

PremiumCompany Announcements

MAIA Biotechnology Highlights Progress in Phase 3 Oncology Program

3M ago

MAIA Biotechnology published a 2026 Letter to Shareholders

PremiumThe FlyMAIA Biotechnology published a 2026 Letter to Shareholders

3M ago

MAIA Biotechnology outlines 2026 goals for ateganosine program

Company Announcements

MAIA Biotechnology outlines 2026 goals for ateganosine program

4M ago

MAIA Biotechnology highlights milestones, catalysts for FY26

The Fly

MAIA Biotechnology highlights milestones, catalysts for FY26

4M ago

MAIA Biotechnology Highlights Strategy in New Investor Presentation

PremiumCompany Announcements

MAIA Biotechnology Highlights Strategy in New Investor Presentation

4M ago

MAIA Biotechnology directors participate in private placement financings

PremiumThe Fly

MAIA Biotechnology directors participate in private placement financings

5M ago

MAIA Biotechnology Announces $2.25M Private Placement Deal

PremiumCompany Announcements

MAIA Biotechnology Announces $2.25M Private Placement Deal

5M ago

MAIA Biotechnology to sell 1.233M shares at $1.22 in private placement

PremiumThe Fly

MAIA Biotechnology to sell 1.233M shares at $1.22 in private placement

5M ago

MAIA Biotechnology announces $1.51M private placement

PremiumThe FlyMAIA Biotechnology announces $1.51M private placement

5M ago

MAIA Biotechnology Announces Significant Insider Buying

Company Announcements

MAIA Biotechnology Announces Significant Insider Buying

5M ago

MAIA Biotechnology doses first patient in Phase 3 trial of ateganosine in NSCLC

The Fly

MAIA Biotechnology doses first patient in Phase 3 trial of ateganosine in NSCLC

5M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >